JPRN-UMIN000022201已完成未知
The efficacy and safety of tocilizumab in patients with neuromyelitis optica - The efficacy and safety of tocilizumab in patients with neuromyelitis optica
Department of Neurology, Shimane University Hospital0 个研究点目标入组 3 人开始时间: 2016年5月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 3
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 74years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with severe infection such at tuberculosis, pneumocystis carinii pneumonia, nontuberculosis mycobacterial infection, hepatitis B,hepatitis C, or chronic active FB virus infection. 2)Patients with a history of hypersensitivity to this drug. 3)Patients with interstitial pneumoniris. 4)Patients with lymphopenia.(lymphocyte number <500/mm3) 5)Pregnant women or patients with possible pregnancy.
研究者
相似试验
已完成
不适用
The safety and efficacy of tocilizumab in patients with neuromyelitis optica: Multicenter Studyneuromyelitis opticaJPRN-UMIN000007866Department of Immunology, National Institute of Neuroscience, NCNP15
已完成
不适用
The safety and efficacy of tocilizumab in patients with neuromyelitis opticaneuromyelitis opticaJPRN-UMIN000005889Department of Immunology, National Institute of Neuroscience, NCNP3
已完成
不适用
Efficacy and Safety of treatment with tocilizumab in refractory patients with Takayasu ArteritisTakayasu arteritisJPRN-UMIN000007845Department of Cardiovascular Medicine Graduate School of Medicine Osaka University15
招募中
不适用
The efficacy and safety of tocilizumab (trade name: Actemra) in RA patients.Rhumatoid arthritisJPRN-UMIN000002843Division of Rheumatology, Department of Internal Medicine, Kanazawa University Graduate School of Medicine20
已完成
不适用
ong-term Safety of treatment with tocilizumab in the refractory patients with Takayasu ArteritisTakayasu arteritisJPRN-UMIN000025943Osaka Unversity9